Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy of Maxidex and Patanol compared to
placebo in patients with allergic conjunctivitis when exposed to controlled allergen levels
in an Environmental Exposure Chamber (EEC).